Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
JOHN ABALLI Insider Profile
4 Followers
JOHN ABALLI, President & CEO, Director at Exagen, holds 689.80K shares in Exagen (Ticker: XGN). Most recently, JOHN ABALLI Bought $24,305 shares of Exagen on Nov 18, 2024 for an estimated value of 68.30K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+50.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that JOHN ABALLI holds in companies
Most Profitable Insider Trade
The most profitable trade made by JOHN ABALLI
JOHN ABALLI's Trading History
List of latest transactions for each holding click on a transaction to see JOHN ABALLI's performance on stock
You May Also Like
JOHN ABALLI insider profile FAQ
What is the percentage of profitable transactions made by JOHN ABALLI?
The percentage of profitable transactions made by JOHN ABALLI is 50%.
What is the average return per transaction made by JOHN ABALLI?
The average return per transaction made by JOHN ABALLI is 50.50%.
What stocks does JOHN ABALLI hold?
JOHN ABALLI holds: XGN stocks.
What was JOHN ABALLI’s latest transaction?
JOHN ABALLI latest transaction was an Informative Buy of $68.30K.
What was JOHN ABALLI's most profitable transaction?
JOHN ABALLI’s most profitable transaction was an Informative Buy of XGN stock on May 16, 2024. The return on the trade was 172.40%.
What is JOHN ABALLI's role in Exagen?
JOHN ABALLI's role in Exagen is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.